Live feed
Filing
SC 13G
SC 13G0001535610-16-000141·Opus Genetics, Inc.
Schedule 13G ownership disclosure
REXAHN PHARMACEUTICALS, INC.
Security class unavailable · CUSIP: 761640101
Event date: 2016-02-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,425,000
- Percent of class
- 4.8900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-16-000141
- Form type
- SC 13G
- Filer
- Opus Genetics, Inc.
- CIK
- CIK 1228627
- Filed
- Feb 29, 2016
- Reporting period
- Feb 26, 2016
- Description
- Schedule 13G beneficial ownership